MedTrace Logo

Effects of N-acetylcysteine on Diabetic Foot Oxygenation

NCT01082445 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2012-03-08

No results posted yet for this study

Summary

The purpose of this study is to determine whether N-acetylcysteine is effective in the treatment or prevention of the foot ulcers in diabetic patients.

Conditions

  • Foot Ulcer, Diabetic

Interventions

DRUG

N-acetylcysteine

600 mg, 1 tablet 3 times a day for 3 months

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • University of Turin, Italy

    lead OTHER

Principal Investigators

  • Valentino Martina, Professor · University of Turin, Italy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01082445 on ClinicalTrials.gov